Next Article in Journal
A Modified Intraperitoneal Chemotherapy Regimen for Ovarian Cancer: Technique and Treatment Outcomes
Next Article in Special Issue
Her2-Positive Cancers and Antibody-Based Treatment: State of the Art and Future Developments
Previous Article in Journal
Heterogeneity of Circulating Tumor Cell Neoplastic Subpopulations Outlined by Single-Cell Transcriptomics
Previous Article in Special Issue
Long-Term Outcomes of a Randomized Study of Neoadjuvant Induction Dual HER2 Blockade with Trastuzumab and Lapatinib Followed by Weekly Paclitaxel Plus Dual HER2 Blockade for HER2-Positive Primary Breast Cancer (Neo-Lath Study)
 
 
Article

Article Versions Notes

Action Date Notes Link
article xml file uploaded 29 September 2021 11:58 CEST Original file -
article xml uploaded. 29 September 2021 11:58 CEST Update https://0-www-mdpi-com.brum.beds.ac.uk/2072-6694/13/19/4884/xml
article pdf uploaded. 29 September 2021 11:58 CEST Version of Record https://0-www-mdpi-com.brum.beds.ac.uk/2072-6694/13/19/4884/pdf
article supplementary file uploaded. 29 September 2021 11:58 CEST - https://0-www-mdpi-com.brum.beds.ac.uk/2072-6694/13/19/4884#supplementary
article html file updated 29 September 2021 12:00 CEST Original file -
article html file updated 30 July 2022 08:22 CEST Update https://0-www-mdpi-com.brum.beds.ac.uk/2072-6694/13/19/4884/html
Back to TopTop